UPDATE 1-GSK lung drug succeeds in big UK study, after earlier miss
May 24, 2016 at 08:45 AM EDT
* 8.4 pct reduction in exacerbations vs standard care (Adds comment from GSK executive and analyst)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.